Comparative study of computer-assisted image analysis and light- microscopically determined estrogen receptor status of breast carcinomas

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 4, 1998, Pages 346-352

  Bejar, Jacob ^a   Sabo, Edmund ^a   Misselevich, Ines ^a   Eldar, Samuel ^a   Boss, Jochanan H ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MICROSCOPY; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL NUCLEUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; RECEPTORS, ESTROGEN; SOFTWARE;

EID: 0031914689     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet. 1992;339:1-15.
2. Andersen J. Determination of oestrogen receptors in paraffin-embedded tissue. Acta Oncol. 1992;31:611-627.
3. Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR. Immunohistochemical detection of p53 protein in mammary carcinoma. Hum Pathol. 1993; 24:469-476.
4. Detre S, Saccani Jotti C, Dowsett M. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 1995;48:876-878.
5. Tesch M, Shawwa A, Henderson R. Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer. Am J Clin Pathol. 1993;99:8-12.
6. Andersen J, Bentzen SM, Poulsen HS. Relationship between radioligand binding assay, immunoenzyme assay and immunohistological assay for oestrogen receptors in human breast cancer and association with tumour differentiation. Eur J Cancer. 1988;24:377-384.
7. Saccani Jotti G, Johnston SRD, Salter J, Detre S, Dowsett M. Comparison of a new immunohistochemical assay for oestrogen receptor in paraffin-embedded breast carcinoma tissue with quantitative enzyme immunoassay. J Clin Pathol. 1994;47:900-905.
8. Kinsel B, Szabo E, Greene GL, Konrath J, Leight GS, McCarty KS. Immunocytochemical analysis of oestrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res. 1989;49:1052-1056.
9. Esteban JM, Kandalaft PL, Mehta P, Odom-Maryon TL, Bacus S, Battifora H. Improvement of the quantification of estrogen and progesterone receptors in paraffin-embedded tumors by image analysis. Am J Clin Pathol. 1993;99:32-38.
10. Loebel J. Image Analysis, Principles and Practice: A Technical Handbook. London, England: Vickers Co; 1992:1-2, 79.
11. Rutquist LE, Cedermark B, Fornander T, et al. The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer. J Clin Oncol. 1989;7:1474-1484.
12. Alberts SR, Ingle JN, Roche PR, et al. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials. Cancer. 1996;78: 764-772.
13. Biesterfeld S, Veuskens U, Schmitz FJ, Amo-Takyi B, Bocking A. Interobserver reproducibility of immunocytochemical estrogen- and progesterone-receptor status assessment in breast cancer. Anticancer Res. 1996;16:2497-2500.